Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1987 Nov;71(11):837–843. doi: 10.1136/bjo.71.11.837

Natural history of retinopathy of prematurity.

W E Schulenburg 1, A Prendiville 1, R Ohri 1
PMCID: PMC1041321  PMID: 3689735

Abstract

Sixty-nine infants at risk of developing retinopathy of prematurity (ROP) were entered into a prospective study to assess the incidence and natural history of the disease. Seventeen infants developed ROP, and in six eyes the disease progressed to stage IV ROP. The natural regression of a pupillary membrane and physiological vitreous haze was not influenced by the onset of ROP. Progression from stage I to stage III was rapid and the rate was influenced by the zone affected. Congestion and tortuosity of vessels in the posterior pole always signified stage III ROP. Progression from stage III to stage IV ROP was slower; it was characterised by the development of vitreoretinopathy, signified by the sudden onset of a vitreous haze. Iris congestion associated with poor mydriasis may be a grave sign indicating imminent retinal detachment. Cicatricial ROP can be divided into retinal and vitreoretinal cicatricial disease directly related to the stage of active disease reached. ROP is characterised by its self limiting nature, but the stage at which it becomes inactive varies and will influence the final outcome.

Full text

PDF
841

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Sira I., Nissenkorn I., Grunwald E., Yassur Y. Treatment of acute retrolental fibroplasia by cryopexy. Br J Ophthalmol. 1980 Oct;64(10):758–762. doi: 10.1136/bjo.64.10.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Flynn J. T. Acute proliferative retrolental fibroplasia: evolution of the lesion. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975;195(2):101–111. doi: 10.1007/BF00417113. [DOI] [PubMed] [Google Scholar]
  3. Flynn J. T., O'Grady G. E., Herrera J., Kushner B. J., Cantolino S., Milam W. Retrolental fibroplasia: I. Clinical observations. Arch Ophthalmol. 1977 Feb;95(2):217–223. doi: 10.1001/archopht.1977.04450020019002. [DOI] [PubMed] [Google Scholar]
  4. Garoon I., Epstein G., Segall M., Rabb M. F., LaFranco F., Quirk T. C., 3rd Vascular tufts in retrolental fibroplasia. Ophthalmology. 1980 Nov;87(11):1128–1132. doi: 10.1016/s0161-6420(80)35120-8. [DOI] [PubMed] [Google Scholar]
  5. Kingham J. D. Acute retrolental fibroplasia. II. Treatment by cryosurgery. Arch Ophthalmol. 1978 Nov;96(11):2049–2053. doi: 10.1001/archopht.1978.03910060437008. [DOI] [PubMed] [Google Scholar]
  6. Machemer R. Closed vitrectomy for severe retrolental fibroplasia in the infant. Ophthalmology. 1983 May;90(5):436–441. doi: 10.1016/s0161-6420(83)34533-4. [DOI] [PubMed] [Google Scholar]
  7. Mousel D. K. Cryotherapy for retinopathy of prematurity. A personal retrospective. Ophthalmology. 1985 Mar;92(3):375–378. doi: 10.1016/s0161-6420(85)34039-3. [DOI] [PubMed] [Google Scholar]
  8. Patz A. Current therapy of retrolental fibroplasia. Retinopathy of prematurity. Ophthalmology. 1983 May;90(5):425–427. doi: 10.1016/s0161-6420(83)34536-x. [DOI] [PubMed] [Google Scholar]
  9. Reisner S. H., Amir J., Shohat M., Krikler R., Nissenkorn I., Ben-Sira I. Retinopathy of prematurity: incidence and treatment. Arch Dis Child. 1985 Aug;60(8):698–701. doi: 10.1136/adc.60.8.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Shohat M., Reisner S. H., Krikler R., Nissenkorn I., Yassur Y., Ben-Sira I. Retinopathy of prematurity: incidence and risk factors. Pediatrics. 1983 Aug;72(2):159–163. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES